Miragen Therapeutics Inc.
13F holders, Q2 2024 (June 30)2holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Miragen Therapeutics Inc. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Game Plan Financial Advisors, LLC ($0) and Tucker Asset Management LLC ($0).
- Company
- Miragen Therapeutics Inc.
- CUSIP
- 604CVR019
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 700 shares sold, net −700 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Game Plan Financial Advisors, LLC | 0.00% | Reduce -9.1% | 7,000 | $0 |
| Tucker Asset Management LLC | 0.00% | No change | 500 | $0 |
"% of holder's portfolio" is MIRAGEN THERAPEUTICS INC's weight in each manager's 13F, not the share of Miragen Therapeutics Inc. the manager owns.